|
LC 14.23:R 44810/
|
FDA Risk Evaluation and Mitigation Strategies (REMS) : description and effect on generic drug development |
1 |
|
LC 14.23:R 44811/
|
Surface transportation devolution |
1 |
|
LC 14.23:R 44812/
|
U.S. strategy for engagement in Central America : policy issues for Congress |
1 |
|
LC 14.23:R 44813/
|
Cost-benefit analysis and financial regulator rulemaking |
1 |
|
LC 14.23:R 44814/
|
NASS and U.S. crop production forecasts : methods and issues |
1 |
|
LC 14.23:R 44816/
|
Congressional news media and the House and Senate press galleries |
1 |
|
LC 14.23:R 44817/
|
U.S.-UK free trade agreement : prospects and issues for Congress |
1 |
|
LC 14.23:R 44818/
|
Gun control, veterans benefits, and mental incompetency determinations |
1 |
|
LC 14.23:R 44819/
|
Senate proceedings establishing majority cloture for Supreme Court nominations : in brief |
1 |
|
LC 14.23:R 44820/
|
Selected international insurance issues in the 115th Congress |
1 |
|
LC 14.23:R 44821/
|
Border-adjusted consumption taxes and exchange rate movements : theory and evidence |
1 |
|
LC 14.23:R 44822/
|
Cuba : U.S. policy in the 115th Congress |
1 |
|
LC 14.23:R 44824/
|
Advanced gene editing : CRISPR-Cas9 |
1 |
|
LC 14.23:R 44825/
|
The earned income tax credit (EITC) : a brief legislative history |
1 |
|
LC 14.23:R 44826/
|
The loan limits for government-backed mortgages |
1 |
|
LC 14.23:R 44827/
|
Law enforcement using and disclosing technology vulnerabilities |
1 |
|
LC 14.23:R 44828/
|
The National Security Council : background and issues for Congress |
1 |
|
LC 14.23:R 44829/
|
Patent boxes : a primer |
1 |
|
LC 14.23:R 44831/
|
Revitalizing coastal shipping for domestic commerce |
1 |
|
LC 14.23:R 44832/
|
Frequently asked questions about prescription drug pricing and policy |
1 |